Azalea Therapeutics

United States
Salem, South Dakota, United States

Company profile

Azalea Therapeutics company profile

Azalea Therapeutics is a biotechnology company pioneering precision genome engineering directly inside the body, with a primary focus on developing cancer immunotherapies. Their innovative approach uses Envelope Delivery Vehicles (EDVs) to selectively locate and deliver genome editing tools to T cells within the patient, enabling the engineering of these cells in vivo rather than ex vivo (outside the body). This method aims to transform the patient’s own T cells into powerful cancer therapies safely and efficiently.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
2023-01-01

Headquarters

Headquarters
Salem, South Dakota, United States
Postal code
94720
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$99M
Last funding
Series A / $65M / 2025-11-04
Last equity funding
Series A / $65M
Investors
6
Lead investors
2
Articles
7

Founders and investors

Lead investors

Sozo VenturesThird Rock Ventures

Investors

Parker Institute for Cancer ImmunotherapyRA Capital ManagementSozo VenturesThird Rock VenturesYosemite

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.